Literature DB >> 15820484

Glutathione metabolism and antioxidant enzymes in patients affected by nonalcoholic steatohepatitis.

Valerio Nobili1, Anna Pastore, Laura Maria Gaeta, Giulia Tozzi, Daniela Comparcola, Maria Rita Sartorelli, Matilde Marcellini, Enrico Bertini, Fiorella Piemonte.   

Abstract

BACKGROUND: Oxidative stress and accumulation of excessive fat in the liver may underlie the pathophysiology of nonalcoholic steatohepatitis (NASH). Given that glutathione blood metabolism may represent an indicator of tissue oxidative status, we analysed the blood profile of various forms of glutathione in children with NASH, and we evaluated the presence of systemic oxidative stress by calculating the oxidised/reduced glutathione ratio (GSSG/GSH). Furthermore, we analysed the catalytic activities of superoxide dismutase (SOD), glutathione peroxidase (GPx), glutathione transferase (GST), and glutathione reductase (GR) in blood of patients.
METHODS: Blood samples were obtained from 21 children with NASH and 28 controls. Total, reduced, oxidised, and protein-bound glutathione concentrations were determined by reversed-phase liquid chromatography with fluorescence detection. Antioxidant enzymes were spectrophotometrically assayed by using specific substrates.
RESULTS: Our findings showed a 1.5-fold increase of GSSG in patients, resulting in a significant rise of the GSSG/GSH ratio. SOD, GPx, and GR activities were not significantly different in NASH respect to controls, whereas GST, which provides the second defence line against oxidative stress, was 17.8% increased.
CONCLUSIONS: Our data demonstrate an impairment of glutathione metabolism and antioxidant enzyme activities in blood of patients with NASH, supporting a consistent role of free radical cytotoxicity in the pathophysiology of the disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15820484     DOI: 10.1016/j.cccn.2004.12.022

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  20 in total

Review 1.  Nrf2: a potential target for new therapeutics in liver disease.

Authors:  A M Bataille; J E Manautou
Journal:  Clin Pharmacol Ther       Date:  2012-08-08       Impact factor: 6.875

2.  A human-type nonalcoholic steatohepatitis model with advanced fibrosis in rabbits.

Authors:  Tomohiro Ogawa; Hideki Fujii; Katsutoshi Yoshizato; Norifumi Kawada
Journal:  Am J Pathol       Date:  2010-05-20       Impact factor: 4.307

Review 3.  Role of Nrf2 in chronic liver disease.

Authors:  Wei Tang; Yong-Fang Jiang; Murugavel Ponnusamy; Mamadou Diallo
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

4.  Effects of amlodipine, captopril, and bezafibrate on oxidative milieu in rats with fatty liver.

Authors:  Zvi Ackerman; Mor Oron-Herman; Talma Rosenthal; Orit Pappo; Gabriela Link; Ben-Ami Sela; Maria Grozovski
Journal:  Dig Dis Sci       Date:  2007-08-22       Impact factor: 3.199

5.  Experimental non-alcoholic fatty liver disease results in decreased hepatic uptake transporter expression and function in rats.

Authors:  Craig D Fisher; Andrew J Lickteig; Lisa M Augustine; Ronald P J Oude Elferink; David G Besselsen; Robert P Erickson; Nathan J Cherrington
Journal:  Eur J Pharmacol       Date:  2009-04-07       Impact factor: 4.432

Review 6.  Nuclear factor (erythroid-derived 2)-like-2 factor (Nrf2), a key regulator of the antioxidant response to protect against atherosclerosis and nonalcoholic steatohepatitis.

Authors:  Anisha A Gupte; Christopher J Lyon; Willa A Hsueh
Journal:  Curr Diab Rep       Date:  2013-06       Impact factor: 4.810

7.  Increased liver oxidative stress and altered PUFA metabolism precede development of non-alcoholic steatohepatitis in SREBP-1a transgenic spontaneously hypertensive rats with genetic predisposition to hepatic steatosis.

Authors:  Hana Malínská; Olena Oliyarnyk; Miriam Hubová; Václav Zídek; Vladimír Landa; Miroslava Simáková; Petr Mlejnek; Ludmila Kazdová; Theodore W Kurtz; Michal Pravenec
Journal:  Mol Cell Biochem       Date:  2009-09-12       Impact factor: 3.396

8.  Influence of dietary lipids on the erythrocyte antioxidant status of hypercholesterolaemic children.

Authors:  Pilar Codoñer-Franch; Amalia Bataller Alberola; José V Domingo Camarasa; María C Escribano Moya; Victoria Valls Bellés
Journal:  Eur J Pediatr       Date:  2008-06-12       Impact factor: 3.183

9.  A Western diet induced NAFLD in LDLR(-/)(-) mice is associated with reduced hepatic glutathione synthesis.

Authors:  Ling Li; Guo-Fang Zhang; Kwangwon Lee; Rocio Lopez; Stephen F Previs; Belinda Willard; Arthur McCullough; Takhar Kasumov
Journal:  Free Radic Biol Med       Date:  2016-03-30       Impact factor: 7.376

Review 10.  Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases.

Authors:  Sudheer K Mantena; Adrienne L King; Kelly K Andringa; Heather B Eccleston; Shannon M Bailey
Journal:  Free Radic Biol Med       Date:  2008-01-03       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.